REQUEST A DEMO
Total
USD $0.00
Search more companies

Baskhanbiopharma Inc. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Baskhanbiopharma Inc. Profile Updated: March 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Baskhanbiopharma Inc. is a company in South Korea, with a head office in Anseong. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was established on April 05, 1986. The total number of employees is currently 106 (2024). The latest financial highlights indicate a net sales revenue drop of 5.16% in 2024. Over the same period, its total assets grew by 6.97%. In 2024, Baskhanbiopharma Inc.’s net profit margin increased by 0.57%.

Headquarters
354, Wondang-Ro, Wongok-Myeon
Anseong; Gyeonggi;

Contact Details: Purchase the Baskhanbiopharma Inc. report to view the information.

Website: http://www.baskhanbio.com

Basic Information
Total Employees:
Purchase the Baskhanbiopharma Inc. report to view the information.
Outstanding Shares:
Purchase the Baskhanbiopharma Inc. report to view the information.
Financial Auditors:
Purchase the Baskhanbiopharma Inc. report to view the information.
Incorporation Date:
April 05, 1986
Company Performance
Financial values in the chart are available after Baskhanbiopharma Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-5.16%
Total Operating Revenue
-3.96%
Operating Profit
31.88%
EBITDA
10.32%
Net Profit/Loss for the Period
0.68%
Total Assets
6.97%
Total Equity
10.18%
Operating Profit Margin
1.6%
Net Profit Margin
0.57%
Return on Equity (ROE)
-0.88%
Debt / Equity
121%
Quick Ratio
1783.12%
Cash Ratio
1.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?